-
Mashup Score: 0Pfizer, Bayer each strike up deals to add in-vivo gene editing to pipeline mix - MedCity News - 2 year(s) ago
As the annual J.P. Morgan HealthCare Conference kicked off Monday, two pharma giants unveiled deals that give them access to in-vivo gene editing technologies. Pfizer is teaming up with Beam Therapeutics to develop new base-editing therapies while Bayer hopes to develop new medicines with the in-vivo CRISPR editing tools of Mammoth Biosciences.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4Key takeaways from Medtronic CEO's presentation at virtual JPM conference - MedCity News - 2 year(s) ago
Geoff Martha participated in the 40th annual J.P. Morgan Healthcare conference virtually explaining key decisions, accepting responsibility for a trifecta of bad news while also signaling that all will be well in the future at the Dublin-based medtech giant.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet-
Here's some of our #JPM2022 coverage if you have missed it: https://t.co/tdvxhkvmN6 #JPMHC22
-
-
Mashup Score: 0
A leader in telemedicine, Teladoc’s stock is on a slide. But company leaders expect that investors will come around as the company continues to grow, gain customers and retain existing patients.
Source: MedCity NewsCategories: General Medicine News, Latest HeadlinesTweet-
Here's some of our #JPM2022 https://t.co/GUiCUhlrNf #JPMHC22
-
-
Mashup Score: 3In a battle over the future of U.S. health care, a question emerges: Is primary care scalable? - 2 year(s) ago
At #JPM2022, investors entertained pitches from a part of the industry known more for its enduring economic problems than its profit potential: the humble primary care practice.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet-
At #JPM2022, investors entertained pitches from a part of the industry known more for its enduring economic problems than its profit potential: the humble primary care practice. https://t.co/qOBcjwwC1x
-
-
Mashup Score: 1JPM 2022: Boston Scientific, Inspire, Nuvasive, Vericel - 2 year(s) ago
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the third day of the meeting.
Source: Medtech InsightCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @medtechMarion: JPM 2022: Boston Scientific, Inspire, Nuvasive, Vericel https://t.co/rWnktFRXY1 #JPM22 #JPM2022 #digitalhealth #orthpedi…
-
-
Mashup Score: 7Partnering | Novartis - 2 year(s) ago
Our commitment is to help accelerate the discovery and development of transformative medicines. It is imperative that we remain open to partnering on, or acquiring, transformational ideas being developed outside our company. Deal making and partnering play a key role in our strategy and are critical to our long-term success.
Source: NovartisCategories: Hem/Oncs, Latest HeadlinesTweet-
In science, great ideas come from all quarters. That’s why @NovartisScience, we don't suffer from “not invented here syndrome." We want to advance the most transformative medicines possible; working with the right partners can be essential. https://t.co/rGj6IZgS2B #JPM2022 https://t.co/zHKTJhYcok
-
-
Mashup Score: 340th Annual J.P. Morgan Health Care Conference - 2 year(s) ago
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry.
Source: www.jpmorgan.comCategories: HIV/AIDS, Latest HeadlinesTweet-
I'm very excited to introduce today's #JPM2022 presentation, "Success in the health-first era: Leveraging science and technology to safeguard your team and maximize performance," featuring @garfield_susan and @eventgaucho, moderated by @j_g_allen. https://t.co/KvXJFHPZx6
-
-
Mashup Score: 2JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet - 2 year(s) ago
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the second day of the meeting.
Source: Medtech InsightCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @medtechMarion: JPM 2022: Abbott, iRhythm, Novocure, Zimmer Biomet https://t.co/q6nau2G4jo #JPM2022 #JPM22 #orthopedics #robotics #Digit…
-
-
Mashup Score: 1JPM 2022: Dexcom, Edwards, J&J, Medtronic, J&J, ResMed - 2 year(s) ago
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the first day of the meeting.
Source: Medtech InsightCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @medtechMarion: JPM 2022: Dexcom, Edwards, J&J, Medtronic, J&J, ResMed https://t.co/SnwOoqgl7O #JPM22 #JPM2022 #Dexcom #diabetes #cardio…
-
-
Mashup Score: 5
Many hospitals are making the transition to newer, more secure monitoring devices in order to increase the security of sensitive…
Source: Business 2 CommunityCategories: Healthcare Professionals, Latest HeadlinesTweet-
4 Benefits of #Blockchain Powered Monitoring Devices [Infographic] by @nowsourcing https://t.co/mYIeje6VWr via @B2Community #JPM2022 #CyberSecurity #HealthTech @IrmaRaste https://t.co/6ghwHU0ids
-
Here's some of our #JPM2022 coverage if you have missed it: https://t.co/n2vBWDCoyO #JPMHC22